|Videos|March 29, 2015

Strategies Pharmacists Can Use to Minimize Negative Patient Outcomes Regarding Controlled Substances

Daniel Abazia, PharmD, BCPS, clinical assistant professor at Ernest Mario School of Pharmacy, talks about strategies pharmacists can use to minimize negative patient outcomes regarding dangerous controlled substances.

This video was recorded at the 5th annual CE conference in March 2015.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Latest CME

Webinar Registration

Improving Outcomes in Fibrosing Interstitial Lung Diseases: Exploring Novel Mechanisms of Action and New Indications to Inform Clinical and Managed Care Decision-Making

Tuesday, September 8, 2026 | 1:00 & 8:00 PM EDT

Webinar Registration

Redefining Care in Polycythemia Vera and Essential Thrombocythemia: Emerging Evidence, Evolving Strategies, and the Pharmacist’s Role

Wednesday, September 9 | Tuesday, September 15 | Wednesday, September 30 at 1:00 PM & 8:00 PM EDT

In-Person Conference

NEIAP Conference 2026

September 11, 2026

Virtual Symposium Registration

Innovations in Narcolepsy Treatment: Emerging Targets and Implications for Managed Care

Thursday, September 10, 2026 | 12:10 PM-1:10 PM EDT

Virtual Symposium Registration

Evolving Treatment Options in Plaque Psoriasis: Implications of Emerging TYK2 Inhibitors for Managed Care

Thursday, September 10, 2026 | 7:00 AM – 8:00 AM EDT

Virtual Symposium Registration

New Treatments in Systemic Lupus Erythematosus to Advance Care: A Managed Care Focus on Nephritis

Friday, September 11, 2026 | 7:00 AM – 8:00 AM EDT

Virtual Symposium Registration

Looking at Patient-Centered Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Through a Value-Based Lens

Friday, September 11, 2026 | 12:10 PM – 1:10 PM EDT

Virtual Event

PBMI 2026

September 10 - September 11, 2026

Virtual Event

Directions in Oncology Pharmacy® 2026 Midwest

Saturday, September 19, 2026 | 8:00 AM – 2:00 PM CT

Webinar Registration

Shingles Vaccination: Opportunities for Pharmacist Interventions to Provide Patient Education

Thursday, September 10 | Tuesday, September 22, 2026 at 1:00 PM and 8:00 PM EDT

Virtual Event

Infectious Disease Day of Education 2026

Thursday, September 24, 2026

Virtual Symposium Registration

Continuing the Conversation—Breaking Barriers in Obesity Management: Localizing Care, Maximizing Treatment Access, and Sustaining Adherence

Friday, October 2, 2026 | 1:00 PM – 2:30 PM EDT

Webinar Registration

Optimizing Antibody-Drug Conjugate Safety: Pharmacist Strategies for Grading, Monitoring, and Supportive Care

Monday, October 5, 2026 | 1:00 PM & 8:00 PM EDT

Webinar Registration

Transforming Generalized Myasthenia Gravis Care: The Evolving Role of Pharmacists in Optimizing Therapy and Long-Term Disease Management

Thursday October 8, 2026 | 1:00 PM & 8:00 PM EDT

Webinar Registration

Evolving Care in IgA Nephropathy: Translating Emerging Evidence Into Care

Virtual Event

Directions in Oncology Pharmacy® 2026 West Coast

Thursday, October 22, 2026 | 8:00 AM – 4:00 PM PT

Virtual Event

Lung Cancer Day of Education 2026

Monday, October 26, 2026

Webinar Registration

Evolving Hidradenitis Suppurativa Management: Advancements in Treatment and Managed Care Integration Across Patient Populations

In-Person + Virtual Event

ASCP 2026

October 30, 2026

Strategies Pharmacists Can Use to Minimize Negative Patient Outcomes Regarding Controlled Substances

Related Content

GLP-1s and the HCM–Sleep Apnea–Obesity Connection

What Pharmacists Should Know About the Ifosfamide Shortage

Are Your Patients Getting Diagnosed Too Late? What Pharmacists Can Do About It

Evolocumab Cuts MACE in At-Risk Patients With No Prior Events in VESALIUS-CV

The PBM Reform Clock Is Running to 2028—Here's What Independent Pharmacies Should Do

Latest CME

Improving Outcomes in Fibrosing Interstitial Lung Diseases: Exploring Novel Mechanisms of Action and New Indications to Inform Clinical and Managed Care Decision-Making

Redefining Care in Polycythemia Vera and Essential Thrombocythemia: Emerging Evidence, Evolving Strategies, and the Pharmacist’s Role

NEIAP Conference 2026

Innovations in Narcolepsy Treatment: Emerging Targets and Implications for Managed Care

Evolving Treatment Options in Plaque Psoriasis: Implications of Emerging TYK2 Inhibitors for Managed Care

New Treatments in Systemic Lupus Erythematosus to Advance Care: A Managed Care Focus on Nephritis

Looking at Patient-Centered Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Through a Value-Based Lens

PBMI 2026

Directions in Oncology Pharmacy® 2026 Midwest

Shingles Vaccination: Opportunities for Pharmacist Interventions to Provide Patient Education

Infectious Disease Day of Education 2026

Continuing the Conversation—Breaking Barriers in Obesity Management: Localizing Care, Maximizing Treatment Access, and Sustaining Adherence

Optimizing Antibody-Drug Conjugate Safety: Pharmacist Strategies for Grading, Monitoring, and Supportive Care

Transforming Generalized Myasthenia Gravis Care: The Evolving Role of Pharmacists in Optimizing Therapy and Long-Term Disease Management

Evolving Care in IgA Nephropathy: Translating Emerging Evidence Into Care

Directions in Oncology Pharmacy® 2026 West Coast

Lung Cancer Day of Education 2026

Evolving Hidradenitis Suppurativa Management: Advancements in Treatment and Managed Care Integration Across Patient Populations

ASCP 2026

Addressing Gaps in Care for the Rapid and Long-Term Management of Hyperkalemia With Novel Oral Potassium Binding Agents: Insights for Managed Care Professionals

Managing Steroid-Refractory Chronic Graft-versus-Host Disease With Novel Therapies: Opportunities for Pharmacist-Led Interventions

Advancing the Idiopathic Pulmonary Fibrosis Treatment Landscape: What’s Next in Care

Sugar, We’re Going Down: Navigating Glycemic Control in the Era of PI3K/AKT Inhibition for Breast Cancer

From Payload to Patient: Managing Toxicities of Antibody-Drug Conjugates Directed at HER2 and TROP2

Best Practice Approaches for Understanding Chronic Obstructive Pulmonary Disease and Precision Medicine Treatment

Advancing Patient Safety: Strategies to Address Safety Risks and Adherence Barriers to Optimize Outcomes for Patients on Injectable Therapies

The Educated Pharmacist: Overcoming Clinical Inertia—An Interactive Case Workshop for Optimizing Insulin Use

Navigating the Complexities of Personalized Prostate Cancer Care: Insights for Oncology Managed Care

Two Targets, One Mission: Optimizing Bispecific Antibody Use in Non-Hodgkin Lymphoma

Advancing Chronic Kidney Disease Detection and Cardiovascular Risk Reduction in Complex Patients

Advancing HER2-Driven Cancer Care, Biomarker Testing, and Pharmacist Innovation

Navigating Outpatient Bispecific Antibody Administration in Lymphoma: Practical Solutions for Community Oncology Practices

Infectious Disease Day of Education 2026

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

Access and Formulary Design Considerations for Nonsteroidal Topical Therapies in Dermatology

Collaborative Practice Agreement Implementation and Adherence: A Practical Roadmap for Oncology Pharmacists

HER2-Positive Metastatic Breast Cancer: A Managed Care Perspective on Emerging Therapies and Clinical Data

An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer

Pharmacogenomics in Practice: Enhancing Patient Care Through Genetic Insights

Targeting the Complement Cascade: Evolving Strategies in the Management of Complement-Mediated Kidney Diseases

Continuing the Conversation: Pharmacist Interventions to Optimize T2D Care and Break Through Clinical Inertia

Hat Trick for Hypertension: Strategies to Improve Outcomes With Single-Pill Combinations

Stop and Smell the ROSis: Translating Molecular Results Into Actionable Pharmacy Practice in ROS1-Rearranged NSCLC

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Influenza Immunization in Older Adults: Enhanced Vaccines and Best Practices for Long-Term Care Pharmacists

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

Minimizing Injection Burden: Anti-VEGF Innovation for Retinal Disease Management

Beyond the Nasal Passage: Managing Chronic Rhinosinusitis With Nasal Polyps With Biologics and Pharmacist-Led Approaches

Pharmacists at the Forefront: Enhancing Targeted Therapy Implementation and Patient Outcomes in Advanced Gastric Cancer

Bridging Clinical and Access Gaps in Phenylketonuria: A Managed Care Perspective

Exploring Immunotherapy Strategies in Endometrial Cancer

Enhancing The Role of Oncology Pharmacists in Multidisciplinary Myeloproliferative Neoplasm Care

Artificial Intelligence in Pharmacy Practice: Validated Tools, Real-World Applications, and Emerging Innovations (Pharmacy Technician Credit)

Artificial Intelligence in Pharmacy Practice: Validated Tools, Real-World Applications, and Emerging Innovations

New Oncology Therapy Approvals for 2025 (Pharmacist Credit)

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

The Pharmacist's Role in Palliative and End of Life Symptom Management

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care